Etiometry Honored at Pediatric Cardiac Intensive Care Society Conference
News and Press Releases
BOSTON, December 23, 2014 — Etiometry received a “Top Abstract” award at the 2014 Pediatric Cardiac Intensive Care Society (PCICS) Conference. Our abstract reported the first retrospective study of the Risk Analytics technology, and was selected out of more than 200 abstracts submitted to the conference. We would like to thank our co-authors, Dr. Melvin Almodovar from Boston Children’s Hospital, and Dr. Peter Laussen from Toronto Sick Kids Hospital.
The abstract, titled “Risk Analytics and Outcome Prediction in Neonates Following Cardiac Surgery” assessed the ability of the Risk Analytics to predict a composite poor outcome and biomarkers for inadequate oxygen delivery. The study was conducted on 274 neonates who had undergone cardiac surgery within the first 30 days of life – a population which costs the U.S. healthcare system approximately $1.4B a year, and represent some of the most difficult patients to manage in the ICU.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery
Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]
Health Tech: Shane Cooke Of Etiometry On How Their Technology Can Make An Important Impact On Our Overall Wellness
An Interview With David Leichner published by Authority Magazine From discussing the five things every health tech founder should know, to the real-world impact of Etiometry’s technology in the ICU, this piece offers a compelling look into the mission driving our team forward every day. Read the full interview HERE
Recent Data Highlights the Critical Role of the Etiometry Platform in Assessing Compliance and Opportunities for Improvement in Neonatal Oxygen Therapy
Abstract presented at the 2025 Pediatric Academic Societies (PAS) Annual Meeting April 28, 2025 – BOSTON – A recent study conducted at Children’s National Hospital in Washington, D.C., examined the role of Etiometry’s near real-time clinical intelligence platform in assessing neonatal oxygen therapy compliance and identifying potential areas for improvement. The findings were presented this […]